查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572080

阿斯匹靈市場：按產品、包裝、劑型、劑量、分銷管道和最終用戶 - 2025-2030 年全球預測

Aspirin Market by Product (Buffered Aspirin, Enteric-Coated Aspirin, Regular Aspirin), Packaging (Blister Packs, Bottles, Sachets), Dosage Form, Dosage, Distribution Channel, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年阿斯匹靈市場價值為24.9億美元，預計到2024年將達到25.8億美元，複合年成長率為4.62%，預計到2030年將達到34.2億美元。

阿斯匹靈是一種廣泛使用的藥物，以其鎮痛、發炎和解熱特性而聞名，是全世界非處方藥和處方藥的主要成分。它的需求主要是因為它在疼痛管理、退燒和預防心血管事件方面的功效，這已經鞏固了它在現代醫學中的地位。該藥物可應用於各種最終用戶，包括用於疼痛管理的個人消費者、用於術後護理的醫療機構以及用於關節炎和心血管保護等慢性疾病的長期醫療保健管理。阿斯匹靈市場的成長受到心血管疾病盛行率增加、老年人口成長以及對疼痛管理解決方案的持續需求等因素的顯著影響。此外，消費者對阿斯匹靈預防保健功效的認知不斷增強，也支持了其廣泛使用。然而，它們受到長期使用相關的嚴重副作用的限制，包括胃腸道併發症，這可能會阻礙它們的廣泛使用。監管挑戰和替代療法的可用性也構成了重大挑戰。開發更安全的製劑（例如緩衝阿斯匹靈）以及探索阿斯匹靈在癌症預防等新治療領域的潛在作用存在機會。投資研發以探索阿斯匹靈的潛力並提高其安全性可提供顯著的競爭優勢。該市場競爭激烈，擁有眾多學名藥廠商，因此透過創新和有針對性的行銷策略實現差異化至關重要。鼓勵市場相關人員專注於策略夥伴關係和聯盟，以加強分銷網路，並參與教育消費者安全使用的宣傳活動。咀嚼片和緩釋片等劑型和給藥方法的創新表明了潛在的​​成長途徑，而對阿斯匹靈廣泛健康用途的持續研究可能會開闢新的、利潤豐厚的市場。

主要市場統計
基準年[2023] 24.9億美元
預測年份 [2024] 25.8億美元
預測年份 [2030] 34.2億美元
複合年成長率（%） 4.62%

市場動態：揭示快速發展的阿斯匹靈市場的關鍵市場洞察

阿斯匹靈市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 心血管疾病盛行率增加
    • 擴大阿斯匹靈在癌症預防和發炎疾病治療的應用
    • 人口老化加劇，更容易罹患慢性病
  • 市場限制因素
    • 提供療效更好、副作用更少的替代藥物
  • 市場機會
    • 研發投資改良阿斯匹靈配方
    • 線上平台和遠端醫療快速成長
  • 市場挑戰
    • 阿斯匹靈新配方和用途核准的嚴格監管要求

波特五力：駕馭阿斯匹靈市場的策略工具

波特的五力架構是了解阿斯匹靈市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解阿斯匹靈市場的外部影響

外部宏觀環境因素在塑造阿斯匹靈市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解阿斯匹靈市場的競爭狀況

阿斯匹靈市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣阿斯匹靈市場供應商的績效評估

FPNV定位矩陣是評估阿斯匹靈市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃阿斯匹靈市場的成功之路

阿斯匹靈市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病盛行率增加
      • 擴大阿斯匹靈在癌症預防和發炎疾病治療的應用
      • 人口老化加劇，更容易罹患慢性病
    • 抑制因素
      • 提供療效更好、副作用更少的替代藥物
    • 機會
      • 投資阿斯匹靈強化配方的研發
      • 線上平台和遠端醫療快速成長
    • 任務
      • 阿斯匹靈新配方和用途核准的嚴格監管要求
  • 市場區隔分析
    • 產品：鎮痛和發炎特性增加了阿斯匹靈的常規使用
    • 最終用戶：阿斯匹靈的廣泛使用導致其在診所的使用不斷增加。
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章阿斯匹靈市場：依產品

  • 緩衝阿斯匹靈
  • 腸溶阿斯匹林
  • 普通阿斯匹林

第7章阿斯匹靈市場：依包裝分類

  • 泡殼包裝
  • 瓶子
  • 小袋

第8章阿斯匹靈市場：按劑型

  • 膠囊
  • 凝膠
  • 粉末
  • 藥片

第 9 章 阿斯匹靈市場：按劑量

  • 高劑量
  • 低劑量
  • 中等劑量

第10章阿斯匹靈市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章阿斯匹靈市場：依最終用戶分類

  • 診所
  • 居家護理
  • 醫院
  • 製藥公司
  • 調查機構

第12章美洲阿斯匹靈市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太阿斯匹靈市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲阿斯匹靈市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • PEARLS 試驗由比爾及梅琳達蓋茲基金會資助，正在與世界各地的機構合作，並使用人工智慧工具來研究預防妊娠毒血症的最佳阿斯匹靈劑量。
  • 戰略分析和建議
Product Code: MRR-976C0ED91C3C

The Aspirin Market was valued at USD 2.49 billion in 2023, expected to reach USD 2.58 billion in 2024, and is projected to grow at a CAGR of 4.62%, to USD 3.42 billion by 2030.

Aspirin, a widely used pharmaceutical agent known for its analgesic, anti-inflammatory, and antipyretic properties, is a staple in both over-the-counter and prescription medications globally. Its necessity primarily stems from its efficacy in managing pain, reducing fever, and preventing cardiovascular events, which has cemented its place in modern medicine. This drug finds applications across a diverse range of end-users, including individual consumers for pain management, healthcare facilities for post-operative care, and long-term healthcare management for chronic conditions like arthritis and cardiovascular protection. The aspirin market's growth is heavily influenced by factors such as increasing prevalence of cardiovascular diseases, rising geriatric population, and the ongoing demand for pain management solutions. Additionally, growing consumer awareness about the preventive healthcare benefits of aspirin fuels its adoption. However, the market faces limitations due to the serious side effects associated with long-term use, including gastrointestinal complications, which may hinder widespread usage. Regulatory challenges and the availability of alternative therapies also pose significant challenges. Opportunities lie in the development of safer formulations, such as buffered aspirin, and the exploration of aspirin's potential role in emerging therapeutic areas like cancer prevention. Investment in R&D to explore aspirin's full potential and improve safety profiles can offer significant competitive advantages. As the market is highly competitive with numerous generic players, differentiation through innovation and targeted marketing strategies is crucial. Market players are recommended to focus on strategic partnerships and collaborations to enhance their distribution networks and engage in awareness campaigns to educate consumers about safe usage. Innovation in dosage forms and delivery methods, like chewables or sustained-release tablets, presents potential growth avenues, while ongoing research into aspirin's broader health applications could reveal new, lucrative markets.

KEY MARKET STATISTICS
Base Year [2023] USD 2.49 billion
Estimated Year [2024] USD 2.58 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 4.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aspirin Market

The Aspirin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases
    • Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
    • Rise in aging population susceptible to chronic diseases
  • Market Restraints
    • Availability of Alternative Medications with improved efficacy and fewer side effects
  • Market Opportunities
    • Investment in R&D for enhanced formulations of aspirin
    • Burgeoning growth in online platforms and telemedicine
  • Market Challenges
    • Stringent regulatory requirements for the approval of new formulations and applications of aspirin

Porter's Five Forces: A Strategic Tool for Navigating the Aspirin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aspirin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aspirin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aspirin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aspirin Market

A detailed market share analysis in the Aspirin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aspirin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aspirin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aspirin Market

A strategic analysis of the Aspirin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aspirin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anhui Chemical Group Co., Ltd., Bayer AG, Bristol-Myers Squibb Company, China Meheco Topfond Pharma Co., Ltd., Cigna Corporation, Divi's Laboratories Limited, Dow Chemical Company, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Globe Quimica S.A., Granules India Limited, Hebei Jiheng (Group) Pharmaceutical Co., Ltd., Hubei Biocause Heilen Pharmaceutical Co., Ltd., Jiangsu Nanjing Huaxing Chemical Co., Ltd., Jiangsu Pioneer Pharma Co., Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Nanjing Well Pharmaceutical Technology Co., Ltd., Pfizer Inc., Sanofi S.A., SEQENS SAS, Shandong Xinhua Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., and Zhenjiang Gaopeng Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Aspirin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Buffered Aspirin, Enteric-Coated Aspirin, and Regular Aspirin.
  • Based on Packaging, market is studied across Blister Packs, Bottles, and Sachets.
  • Based on Dosage Form, market is studied across Capsules, Gels, Powders, and Tablets.
  • Based on Dosage, market is studied across High-Dose, Low-Dose, and Medium-Dose.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on End Users, market is studied across Clinics, Home Care, Hospitals, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases
      • 5.1.1.2. Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
      • 5.1.1.3. Rise in aging population susceptible to chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of Alternative Medications with improved efficacy and fewer side effects
    • 5.1.3. Opportunities
      • 5.1.3.1. Investment in R&D for enhanced formulations of aspirin
      • 5.1.3.2. Burgeoning growth in online platforms and telemedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for the approval of new formulations and applications of aspirin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing utilization of regular aspirin owing to its pain-relieving and anti-inflammatory properties
    • 5.2.2. End Users: Evolving utilization of aspirin across the clinics owing to its broad availability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aspirin Market, by Product

  • 6.1. Introduction
  • 6.2. Buffered Aspirin
  • 6.3. Enteric-Coated Aspirin
  • 6.4. Regular Aspirin

7. Aspirin Market, by Packaging

  • 7.1. Introduction
  • 7.2. Blister Packs
  • 7.3. Bottles
  • 7.4. Sachets

8. Aspirin Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Capsules
  • 8.3. Gels
  • 8.4. Powders
  • 8.5. Tablets

9. Aspirin Market, by Dosage

  • 9.1. Introduction
  • 9.2. High-Dose
  • 9.3. Low-Dose
  • 9.4. Medium-Dose

10. Aspirin Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Aspirin Market, by End Users

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Care
  • 11.4. Hospitals
  • 11.5. Pharmaceutical Companies
  • 11.6. Research Institutes

12. Americas Aspirin Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Aspirin Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Aspirin Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. PEARLS trial, funded by Bill and Melinda Gates Foundation, explores optimal aspirin doses to prevent pre-eclampsia, collaborating with global institutions and utilizing AI tools
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Anhui Chemical Group Co., Ltd.
  • 3. Bayer AG
  • 4. Bristol-Myers Squibb Company
  • 5. China Meheco Topfond Pharma Co., Ltd.
  • 6. Cigna Corporation
  • 7. Divi's Laboratories Limited
  • 8. Dow Chemical Company
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. GlaxoSmithKline PLC
  • 11. Globe Quimica S.A.
  • 12. Granules India Limited
  • 13. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
  • 14. Hubei Biocause Heilen Pharmaceutical Co., Ltd.
  • 15. Jiangsu Nanjing Huaxing Chemical Co., Ltd.
  • 16. Jiangsu Pioneer Pharma Co., Ltd.
  • 17. Lupin Pharmaceuticals, Inc.
  • 18. Merck & Co., Inc.
  • 19. Mylan N.V.
  • 20. Nanjing Well Pharmaceutical Technology Co., Ltd.
  • 21. Pfizer Inc.
  • 22. Sanofi S.A.
  • 23. SEQENS SAS
  • 24. Shandong Xinhua Pharmaceutical Co., Ltd.
  • 25. Sun Pharmaceutical Industries Ltd.
  • 26. Taj Pharmaceuticals Ltd.
  • 27. Zhenjiang Gaopeng Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ASPIRIN MARKET RESEARCH PROCESS
  • FIGURE 2. ASPIRIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ASPIRIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ASPIRIN MARKET DYNAMICS
  • TABLE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ASPIRIN MARKET SIZE, BY BUFFERED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ASPIRIN MARKET SIZE, BY ENTERIC-COATED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ASPIRIN MARKET SIZE, BY REGULAR ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ASPIRIN MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ASPIRIN MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ASPIRIN MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ASPIRIN MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ASPIRIN MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ASPIRIN MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ASPIRIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ASPIRIN MARKET SIZE, BY HIGH-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ASPIRIN MARKET SIZE, BY LOW-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ASPIRIN MARKET SIZE, BY MEDIUM-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ASPIRIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ASPIRIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ASPIRIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ASPIRIN MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ASPIRIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ASPIRIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 284. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023